Anna L Peters1, Emma K Van De Weerdt1, Eline J Goudswaard1, Jan M Binnekade1, Jaap J Zwaginga2,3, Erik A M Beckers4, Sacha S Zeerleder5,6, Marian G J Van Kraaij7, Nicole P Juffermans1,8, Alexander P J Vlaar1,8. 1. Department of Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands. 2. Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, the Netherlands. 3. Centre for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands. 4. Department of Internal Medicine-Haematology, Maastricht University Medical Centre, Maastricht, the Netherlands. 5. Department of Haematology, Academic Medical Centre, Amsterdam, the Netherlands. 6. Department of Immunopathology, Sanquin Research, Amsterdam, the Netherlands. 7. Department of Transfusion Medicine, Sanquin Blood Bank, Amsterdam, the Netherlands. 8. Laboratory of Experimental Intensive Care Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Abstract
BACKGROUND: Disciplines involved in diagnosing transfusion-related acute lung injury (TRALI) report according to a "one-hit" theory. However, studies showed that patients with an underlying condition are at increased risk of the development of TRALI. We investigated whether accumulating evidence on the "two-hit" theory has changed the practice of reporting TRALI. MATERIALS AND METHODS: Departments of haematology, haemovigilance, transfusion medicine, intensive care and anaesthesiology from all Dutch hospitals with at least five beds equipped for mechanical ventilation were invited to participate in an online survey. Using clinical vignettes with conjoint analysis we investigated the effect of patients' age, admission diagnosis, type and number of transfusions and presence of risk factors for acute lung injury on TRALI reporting. A positive β-coefficient indicated a higher likelihood of reporting TRALI. RESULTS: We received 129 questionnaires (response rate 74%). Respondents were more likely to report TRALI in younger patients, if symptoms developed within 2 hours of transfusion and if patients had received multiple transfusions. Sepsis and the presence of a risk factor for acute lung injury reduced the inclination to report. Transfusion medicine physicians and haemovigilance staff no longer took the age of transfusion products into account in their diagnostic considerations on TRALI. DISCUSSION: We conclude that the multidisciplinary team involved in TRALI reporting, still considers TRALI a "one-hit" event, despite accumulating evidence that supports the "two-hit" theory. These results suggest that the patients most at risk of developing TRALI are not reported to the blood bank.
BACKGROUND: Disciplines involved in diagnosing transfusion-related acute lung injury (TRALI) report according to a "one-hit" theory. However, studies showed that patients with an underlying condition are at increased risk of the development of TRALI. We investigated whether accumulating evidence on the "two-hit" theory has changed the practice of reporting TRALI. MATERIALS AND METHODS: Departments of haematology, haemovigilance, transfusion medicine, intensive care and anaesthesiology from all Dutch hospitals with at least five beds equipped for mechanical ventilation were invited to participate in an online survey. Using clinical vignettes with conjoint analysis we investigated the effect of patients' age, admission diagnosis, type and number of transfusions and presence of risk factors for acute lung injury on TRALI reporting. A positive β-coefficient indicated a higher likelihood of reporting TRALI. RESULTS: We received 129 questionnaires (response rate 74%). Respondents were more likely to report TRALI in younger patients, if symptoms developed within 2 hours of transfusion and if patients had received multiple transfusions. Sepsis and the presence of a risk factor for acute lung injury reduced the inclination to report. Transfusion medicine physicians and haemovigilance staff no longer took the age of transfusion products into account in their diagnostic considerations on TRALI. DISCUSSION: We conclude that the multidisciplinary team involved in TRALI reporting, still considers TRALI a "one-hit" event, despite accumulating evidence that supports the "two-hit" theory. These results suggest that the patients most at risk of developing TRALI are not reported to the blood bank.
Authors: Alexander P J Vlaar; Jorrit J Hofstra; Wim Kulik; Henk van Lenthe; Rienk Nieuwland; Marcus J Schultz; Marcel M Levi; Joris J T H Roelofs; Anton T J Tool; Dirk de Korte; Nicole P Juffermans Journal: Blood Date: 2010-05-17 Impact factor: 22.113
Authors: Marcella C A Müller; Danielle van Stein; Jan M Binnekade; Dick J van Rhenen; Alexander P J Vlaar Journal: Transfusion Date: 2014-08-18 Impact factor: 3.157
Authors: Mark R Looney; Nareg Roubinian; Ognjen Gajic; Michael A Gropper; Rolf D Hubmayr; Clifford A Lowell; Peter Bacchetti; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Ping Wu; Barbara Grimes; Philip J Norris; Edward L Murphy; Manish J Gandhi; Jeffrey L Winters; David C Mair; Randy M Schuller; Nora V Hirschler; Rosa Sanchez Rosen; Michael A Matthay; Pearl Toy Journal: Crit Care Med Date: 2014-07 Impact factor: 7.598
Authors: Gavin J Murphy; Katie Pike; Chris A Rogers; Sarah Wordsworth; Elizabeth A Stokes; Gianni D Angelini; Barnaby C Reeves Journal: N Engl J Med Date: 2015-03-12 Impact factor: 91.245
Authors: Pearl Toy; Peter Bacchetti; Barbara Grimes; Ognjen Gajic; Edward L Murphy; Jeffrey L Winters; Michael A Gropper; Rolf D Hubmayr; Michael A Matthay; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Nora V Hirschler; Clifford A Lowell; Randy M Schuller; Manish J Gandhi; Philip J Norris; David C Mair; Rosa Sanchez Rosen; Mark R Looney Journal: Transfusion Date: 2014-12-08 Impact factor: 3.157
Authors: Stephen E Wright; Christopher P Snowden; Sally C Athey; Alice A Leaver; Jill-Marie Clarkson; Catherine E Chapman; David R D Roberts; Jonathan P Wallis Journal: Crit Care Med Date: 2008-06 Impact factor: 7.598
Authors: Alexander P J Vlaar; Jan M Binnekade; David Prins; Danielle van Stein; Jorrit J Hofstra; Marcus J Schultz; Nicole P Juffermans Journal: Crit Care Med Date: 2010-03 Impact factor: 7.598
Authors: Marie-Belle El Mdawar; Blandine Maître; Stéphanie Magnenat; Christian Gachet; Béatrice Hechler; Henri de la Salle Journal: Sci Rep Date: 2019-03-26 Impact factor: 4.379
Authors: Alexander P J Vlaar; Pearl Toy; Mark Fung; Mark R Looney; Nicole P Juffermans; Juergen Bux; Paula Bolton-Maggs; Anna L Peters; Christopher C Silliman; Daryl J Kor; Steve Kleinman Journal: Transfusion Date: 2019-04-16 Impact factor: 3.157